INOVIQ

INOVIQ Ltd is developing and commercializing next-generation exosome solutions and precision diagnostic technologies to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the EXO-Net pan-exosome capture tool for research purposes and the hTERT test as an adjunct to urine cytology testing for bladder cancer. Our cancer diagnostics pipeline includes blood tests in development for the early detection and monitoring of ovarian cancer, breast cancer, and other cancers.